Simcere Pharmaceutical Group Ltd.

About

Chinese specialty pharmaceutical company developing and commercialising innovative drugs for neurological, oncological, and auto-immune diseases, with a growing consumer health portfolio of neurology-adjacent OTC and functional health products. Listed on the Hong Kong Stock Exchange with a pipeline of novel small-molecule and biologic drugs.

Categories

Medical & Healthcare SuppliesSupplements & Wellness

Primary markets

🇨🇳 China 🇺🇸 United States 🇩🇪 Germany 🇯🇵 Japan 🇭🇰 Hong Kong

Certifications

ISO 9001 — Quality ManagementGood Manufacturing PracticeISO 14001 — Environmental Management